Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"Bayer, Clinician",Aflibercept,"Wet age-related macular degeneration, 3rd-line",Aflibercept (Eylea),Recommended for decline,Hospital,Sensory Organs
